GE Healthcare offers the only FDA-approved ultrasound supplemental technology that is specifically designed for detecting cancer in dense breast tissue. Compared to mammography alone, InveniaTM ABUS 2.0 imaging looks differently at dense breast tissue, providing a comprehensive view of the breast.
GE Healthcare offers the only FDA-approved ultrasound supplemental technology that is specifically designed for detecting cancer in dense breast tissue. Compared to mammography alone, InveniaTM ABUS 2.0 imaging looks differently at dense breast tissue, providing a comprehensive view of the breast.

COVID-19
Mobilising by your side

Products

Invenia ABUS

Invenia™ ABUS 2.0

Use remarkable image quality, the coronal view, and advanced interpretation tools to look differently at dense breast tissue for adjunctive screening and diagnostic exams.
Learn More